Spots Global Cancer Trial Database for radiopharmaceutical
Every month we try and update this database with for radiopharmaceutical cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma | NCT01898273 | Glioblastoma | I-124-CLR1404 | 18 Years - | Cellectar Biosciences, Inc. | |
| Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma | NCT02278315 | Multiple Myelom... | I-131-CLR1404 dexamethasone I-131-CLR1404 | 18 Years - | Cellectar Biosciences, Inc. | |
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Positron Emission Tomography in Patients With Breast Cancer | NCT00001385 | Breast Neoplasm... | - | National Institutes of Health Clinical Center (CC) | ||
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours | NCT05363605 | Advanced Solid ... Head and Neck S... Bladder Carcino... Susceptible FGF... FGFR3 FGFR3 Overexpre... FGFR3 Receptor FGFR3 Protein O... Ovarian Cancer Colorectal Canc... Breast Cancer Liver Cancer Lung Cancer Gastric Cancer | [225Ac]-FPI-196... [111In]-FPI-196... vofatamab | 18 Years - | Fusion Pharmaceuticals Inc. | |
| ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid | NCT00339131 | Pheochromocytom... Paraganglioma Carcinoid | Ultratrace iobe... | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma | NCT00458952 | Pheochromocytom... Paraganglioma | Ultratrace Iobe... | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy | NCT04904120 | Melanoma (Skin) Melanoma Stage ... Melanoma, Uveal Melanoma, Mucos... | [203Pb]VMT01 [68Ga]VMT02 | 18 Years - 89 Years | Perspective Therapeutics | |
| Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors | NCT00925275 | Solid Tumors | I-131-CLR1404 | 18 Years - | Cellectar, Inc | |
| A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy | NCT03612466 | Osteosarcoma Bone Metastases | 153Sm-DOTMP External beam r... Calcium Carbona... Mozobil Neupogen Inject... | 15 Years - 65 Years | Albert Einstein College of Medicine | |
| A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects | NCT03561259 | Neuroblastoma Neuroectodermal... Neoplasms | 131I-MIBG 131-MIBG + Vori... | 1 Year - | Jubilant DraxImage Inc. | |
| Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC | NCT05595460 | SCLC,Extensive ... | RYZ101 Dose Lev... RYZ101 Dose Lev... RYZ101 Dose Lev... RYZ101 Dose Lev... Atezolizumab Carboplatin Etoposide | 18 Years - | RayzeBio, Inc. | |
| Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014 | NCT01763554 | Neuroendocrine ... | Lu-177 DOTA-TAT... | 14 Years - 90 Years | AHS Cancer Control Alberta |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
